对于高风险的局部性前列腺癌的病理敏感性的预后值,接受新辅助激素治疗与激进前列腺切除术相结合

相关实验视频

Updated: May 17, 2025

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.4K

Kai Shi1,2, Shouzhen Chen1, Xueli Wang3

  • 1Department of Urology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

Annals of medicine
|April 2, 2025
PubMed
概括

在新辅助激素治疗 (NHT) 后,前列腺癌 (PCa) 的新病理反应分级系统可以预测患者的生存率. 与耐药患者相比,对药物敏感的患者的整体和无进展生存时间明显更长.

关键词:
前列腺癌是什么意思 前列腺癌是什么意思不同的病理反应.新辅助性荷尔蒙治疗新辅助性荷尔蒙治疗总体存活率 总体存活率没有进展的生存率.

更多相关视频

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

592

相关概念视频

Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
150